New vaccine for childhood pneumonia enters final testing phase
NCT ID NCT06617715
Summary
This study is testing a new version of a vaccine designed to protect infants and young children from serious pneumococcal infections, like some types of pneumonia and meningitis. It will enroll 3080 healthy children, from 6 weeks to under 6 years old, to compare the safety and immune response of the new vaccine against an already approved one. The goal is to see if the new vaccine works as well and is as safe for preventing these bacterial diseases.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PNEUMOCOCCAL INFECTIOUS DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Henan Provincial Center for Disease Control and Prevention
RECRUITINGZhengzhou, Henan, China
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.